Anebulo Pharmaceuticals, Inc.
NASDAQ:ANEB
1.5955 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -8.202 | -11.732 | -6.826 | -30.253 | -0.175 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.759 | 0.885 | 0.481 | 0.2 | 0 |
| Change In Working Capital
| -0.799 | 1.164 | 0.908 | -1.445 | 0.023 |
| Accounts Receivables
| 0 | 0 | 0 | 0.004 | 0 |
| Inventory
| 0 | 0 | 0 | -0.004 | 0 |
| Accounts Payables
| -0.378 | 0.154 | 0.271 | 0.11 | 0 |
| Other Working Capital
| -0.421 | -0.154 | 0.637 | -1.555 | 0.023 |
| Other Non Cash Items
| 0.151 | 0.731 | 0.21 | 26.627 | 0.001 |
| Operating Cash Flow
| -8.091 | -9.683 | -5.437 | -4.871 | -0.151 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | -0.201 | 0.2 |
| Common Stock Issued
| 0.654 | 6.647 | 0 | 22.855 | 2.976 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.062 | -0.265 | 0 | -0.822 | 0 |
| Financing Cash Flow
| -0.062 | 6.382 | 0 | 21.832 | 3.176 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -8.153 | -3.301 | -5.437 | 16.961 | 3.025 |
| Cash At End Of Period
| 3.094 | 11.247 | 14.548 | 19.986 | 3.025 |